Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...

Health experts are encouraging women to prioritize bone health as they approach menopause, warning that osteoporosis often ...

Fact checked by Jennifer Klump About the Author Kelly Wood, MD, is a board-certified endocrinologist specializing in osteoporosis and metabolic bone disease. She also treats adults with diabetes, ...

"NFLM." "Not Feeling Like Myself." "I don't feel like myself" actually has been studied, that exact phrase, and it is likely ...

Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, ...

As of early 2026, no additional agents beyond palopegteriparatide have received FDA approval for hypoparathyroidism. Several promising therapies for hypoparathyroidism (hypoPT) are currently in ...

An estimated 10 million Americans are living with osteoporosis, and another 44 million have low bone density, putting them at ...

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 ...

Vitamin K2 activates proteins that help drive calcium into the bones, away from blood vessels and heart valves. So, the ...

Doctors break it down.

Transaction adds TYMLOS® to portfolio alongside NUZYRA® and XHANCE® and creates a diversified portfolio expected to generate nearly $1 billion in revenue in 2026 KING OF PRUSSIA, Pa., March 18, 2026 ...